CVE-2026-123052: The CeliachiaRL integration component distributed with Farmasimplex uses shared OAuth credentials
Source GCVE Database
Not known to be exploited · CVSS 4.7 Medium : upgrade to 16.2.0 when convenient.
Data as of 17 Nov 2026, 16:50 UTC
Thin evidence
One scorer or none| CNA (ENISA) | CVSS 4.0 | 4.7 |
|---|
- Patch
- Available – fixed in 16.2.0
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:UExploitation evidence
Disclosed: evidence found.
CVE published 17 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 16 Nov 2026.
What to do
Upgrade Farmasimplex CeliachiaRL to 16.2.0.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| CIPCarboneFarmasimplex CeliachiaRL | Affected
| Fixed in
|
AI-suggested
Since the vulnerability involves shared OAuth credentials, mitigation should focus on isolating credentials per installation and rotating compromised credentials if possible. Until a fix is provided, avoid sharing OAuth credentials across multiple installations.
Description
The CeliachiaRL integration component used in Farmasimplex shares OAuth credentials across multiple customer installations. This shared credential usage allows an attacker who obtains credentials from one installation to potentially access or modify data in other installations. The vulnerability could lead to unauthorized access to sensitive information or unauthorized modification of integration data.